Table 3.

Conversion rate expressed as [D3G]/[TDON] (where TDON is the sum of DON, D3G and ADON) obtained at each sampling stage for the DON-treated lines considered in the second trial.

Sampling dates	Kofa	Svevo	Sumai-3
Sd1	0.046	0.056	0.246
Sd2	0.391	0.154	0.655
Sd5	0.421	0.115	0.619
SH	0.530	0.312	0.843